Kenjiro Sawada Selected Research

Kenjiro Sawada Research Topics

Disease

61	Neoplasms (Cancer) 03/2022 - 11/2002
32	Ovarian Neoplasms (Ovarian Cancer) 01/2021 - 11/2002
12	Uterine Cervical Neoplasms (Cancer of the Cervix) 09/2021 - 07/2014
11	Neoplasm Metastasis (Metastasis) 11/2021 - 12/2002
10	Carcinoma (Carcinomatosis) 09/2018 - 04/2005
5	Endometrial Neoplasms (Endometrial Cancer) 03/2022 - 02/2015
5	Carcinogenesis 11/2021 - 02/2008
5	Adenocarcinoma 10/2017 - 06/2011
5	Ascites 01/2015 - 01/2005
4	Ovarian Epithelial Carcinoma 01/2021 - 11/2018
4	Osteoporosis 01/2017 - 11/2002
4	Hypoxia (Hypoxemia) 05/2015 - 10/2004
3	Postmenopausal Osteoporosis 01/2020 - 06/2003
3	Infections 03/2016 - 02/2007
2	Uterine Neoplasms (Uterine Cancer) 03/2022 - 01/2018
2	Endometriosis 01/2022 - 08/2016
2	Chorioamnionitis 03/2016 - 11/2013
2	Inflammation (Inflammations) 03/2016 - 11/2013
1	Anemia 01/2022
1	Fatigue 01/2022
1	Diarrhea 09/2021
1	Venous Thromboembolism 11/2019
1	Breast Neoplasms (Breast Cancer) 03/2019
1	Thrombocytosis (Thrombocythemia) 01/2019
1	Leukocytosis (Pleocytosis) 01/2019

Drug/Important Bio-Agent (IBA)

8	MicroRNAs (MicroRNA)IBA 01/2020 - 05/2013
8	Proteins (Proteins, Gene)FDA Link 08/2019 - 11/2002
8	IntegrinsIBA 01/2019 - 02/2007
7	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2021 - 07/2014
5	PlatinumIBA 10/2019 - 12/2015
5	Pharmaceutical PreparationsIBA 01/2019 - 04/2007
5	Cisplatin (Platino)FDA LinkGeneric 11/2018 - 09/2009
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2016 - 03/2007
5	lysophosphatidic acidIBA 12/2009 - 11/2002
5	rho-Associated KinasesIBA 12/2009 - 11/2002
5	Tyrosine (L-Tyrosine)FDA Link 04/2007 - 11/2002
4	Indicators and Reagents (Reagents)IBA 01/2021 - 06/2011
4	Neutralizing AntibodiesIBA 03/2019 - 07/2014
4	Interleukin-6 (Interleukin 6)IBA 01/2019 - 11/2013
4	Alendronate (Alendronate Sodium)FDA LinkGeneric 01/2009 - 11/2002
3	Mevalonic Acid (Mevalonate)IBA 01/2021 - 11/2002
3	Paclitaxel (Taxol)FDA LinkGeneric 10/2020 - 01/2015
3	Biological ProductsIBA 03/2019 - 07/2014
3	Irinotecan (Camptosar)FDA LinkGeneric 01/2019 - 06/2014
3	Biomarkers (Surrogate Marker)IBA 09/2018 - 01/2014
3	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 10/2017 - 02/2007
3	Phosphotransferases (Kinase)IBA 05/2016 - 02/2007
3	Messenger RNA (mRNA)IBA 04/2009 - 10/2004
3	Diphosphonates (Bisphosphonates)IBA 01/2005 - 11/2002
2	TOR Serine-Threonine KinasesIBA 12/2020 - 09/2009
2	Dinoprostone (PGE2)FDA Link 12/2020 - 11/2018
2	YM 529IBA 01/2020 - 01/2017
2	PM 01183IBA 10/2019 - 01/2016
2	LipidsIBA 08/2019 - 02/2015
2	Estrogens (Estrogen)FDA Link 03/2019 - 01/2018
2	Celecoxib (Celebrex)FDA Link 01/2019 - 11/2018
2	VitronectinIBA 11/2018 - 10/2017
2	taxaneIBA 10/2018 - 12/2017
2	Raloxifene Hydrochloride (Evista)FDA Link 01/2017 - 02/2015
2	Small Interfering RNA (siRNA)IBA 01/2017 - 02/2007
2	CytokinesIBA 03/2016 - 11/2013
2	Antineoplastic Agents (Antineoplastics)IBA 01/2016 - 12/2009
2	Bevacizumab (Avastin)FDA Link 04/2015 - 08/2010
2	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 01/2015 - 11/2013
2	TrabectedinIBA 06/2014 - 07/2011
2	Everolimus FDA Link 07/2011 - 09/2009
2	Oxygen (Dioxygen)IBA 09/2009 - 10/2004
2	Cadherins (E-Cadherin)IBA 09/2009 - 04/2008
2	Peptide Hydrolases (Proteases)FDA Link 02/2008 - 02/2007
2	geranylgeranylacetone (teprenone)IBA 04/2007 - 04/2005
2	NitrogenIBA 01/2005 - 11/2002
1	ninjin'yoeitoIBA 01/2022
1	Asu(1,6)- argipressin (VAS-A)IBA 01/2022
1	Hemoglobins (Hemoglobin)IBA 01/2022
1	IronIBA 01/2022
1	Galectin 3 (LGALS3)IBA 01/2022
1	GW 4869IBA 01/2021
1	Farnesyl-Diphosphate Farnesyltransferase (Squalene Synthase)IBA 01/2021
1	SqualeneIBA 01/2021
1	Ubiquitin-Specific ProteasesIBA 01/2021
1	B7-H1 AntigenIBA 12/2020
1	Aldehyde Dehydrogenase 1 FamilyIBA 12/2020
1	Denosumab FDA Link 01/2020
1	AnticoagulantsIBA 11/2019
1	Vitamin K FDA Link 11/2019
1	Nucleic AcidsIBA 08/2019
1	Estrogen ReceptorsIBA 03/2019
1	Fibronectins (Fibronectin)IBA 11/2018

Therapy/Procedure

23	Therapeutics 01/2022 - 12/2002
6	Drug Therapy (Chemotherapy) 01/2019 - 01/2015
6	Hysterectomy 10/2017 - 01/2012
5	Radiotherapy 09/2021 - 07/2014
3	Aftercare (After-Treatment) 01/2022 - 02/2015
2	Laparotomy 03/2022 - 03/2011
2	Lymph Node Excision (Lymph Node Dissection) 03/2022 - 02/2015
2	Kampo Medicine (Kampo) 01/2022 - 01/2018
2	Brachytherapy 05/2021 - 03/2019
2	Combination Drug Therapy (Combination Chemotherapy) 10/2018 - 12/2017
2	Splenectomy 12/2015 - 07/2014
1	Chemoradiotherapy 09/2021